Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis

<p>Abstract</p> <p>Backround</p> <p>The emergence of <it>Mycobacterium tuberculosis </it>strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR...

Full description

Bibliographic Details
Main Authors: Oymak Sema F, Gulmez Inci, Tor Meltem, Altın Remzi, Kart Levent, Atmaca Hulusi M, Erdem Funda
Format: Article
Language:English
Published: BMC 2002-12-01
Series:Annals of Clinical Microbiology and Antimicrobials
Subjects:
Online Access:http://www.ann-clinmicrob.com/content/1/1/6
_version_ 1811312098232238080
author Oymak Sema F
Gulmez Inci
Tor Meltem
Altın Remzi
Kart Levent
Atmaca Hulusi M
Erdem Funda
author_facet Oymak Sema F
Gulmez Inci
Tor Meltem
Altın Remzi
Kart Levent
Atmaca Hulusi M
Erdem Funda
author_sort Oymak Sema F
collection DOAJ
description <p>Abstract</p> <p>Backround</p> <p>The emergence of <it>Mycobacterium tuberculosis </it>strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB).</p> <p>Methods</p> <p>Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method.</p> <p>Results</p> <p>Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05).</p> <p>Conclusion</p> <p>This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains.</p>
first_indexed 2024-04-13T10:30:15Z
format Article
id doaj.art-255439033fc8425690235d52342fa549
institution Directory Open Access Journal
issn 1476-0711
language English
last_indexed 2024-04-13T10:30:15Z
publishDate 2002-12-01
publisher BMC
record_format Article
series Annals of Clinical Microbiology and Antimicrobials
spelling doaj.art-255439033fc8425690235d52342fa5492022-12-22T02:50:12ZengBMCAnnals of Clinical Microbiology and Antimicrobials1476-07112002-12-0111610.1186/1476-0711-1-6Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysisOymak Sema FGulmez InciTor MeltemAltın RemziKart LeventAtmaca Hulusi MErdem Funda<p>Abstract</p> <p>Backround</p> <p>The emergence of <it>Mycobacterium tuberculosis </it>strains resistant to antituberculosis agents has recently received increased attention owing largely to the dramatic outbreaks of multi drug resistance tuberculosis (MDR-TB).</p> <p>Methods</p> <p>Patients residing in Zonguldak and Kayseri provinces of Turkey with, pulmonary tuberculosis diagnosed between 1972 and 1999 were retrospectively identified. Drug susceptibility tests had been performed for isoniazid (INH), rifampin (RIF), streptomycin (SM), ethambutol (EMB) and thiacetasone (TH) after isolation by using the resistance proportion method.</p> <p>Results</p> <p>Total 3718 patients were retrospectively studied. In 1972–1981, resistance rates for to SM and INH were found to be 14.8% and 9.8% respectively (n: 2172). In 1982–1991 period, resistance rates for INH, SM, RIF, EMB and TH were 14.2%, 14.4%, 10.5%, 2.7% and 2.9% (n: 683), while in 1992–1999 period 14.4%, 21.1%, 10.6%, 2.4% and 3.7% respectively (n: 863). Resistance rates were highest for SM and INH in three periods. MDR-TB patients constituted 7.3% and 6.6% of 1982–1991 and 1992–1999 periods (p > 0.05).</p> <p>Conclusion</p> <p>This study demonstrates the importance of resistance rates for TB. Continued surveillance and immediate therapeutic decisions should be undertaken in order to prevent the dissemination of such resistant strains.</p>http://www.ann-clinmicrob.com/content/1/1/6TuberculosisDrug resistanceEpidemiologyTurkey
spellingShingle Oymak Sema F
Gulmez Inci
Tor Meltem
Altın Remzi
Kart Levent
Atmaca Hulusi M
Erdem Funda
Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
Annals of Clinical Microbiology and Antimicrobials
Tuberculosis
Drug resistance
Epidemiology
Turkey
title Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_full Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_fullStr Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_full_unstemmed Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_short Antituberculosis drug resistance patterns in two regions of Turkey: a retrospective analysis
title_sort antituberculosis drug resistance patterns in two regions of turkey a retrospective analysis
topic Tuberculosis
Drug resistance
Epidemiology
Turkey
url http://www.ann-clinmicrob.com/content/1/1/6
work_keys_str_mv AT oymaksemaf antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT gulmezinci antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT tormeltem antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT altınremzi antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT kartlevent antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT atmacahulusim antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis
AT erdemfunda antituberculosisdrugresistancepatternsintworegionsofturkeyaretrospectiveanalysis